Skip to content

Does adding patient-controlled sedation with propofol during repair of obstetric perineal lacerations grade I and II improve patient experiences - a randomized control trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502292-39-00
Acronym
PROP(ofol)
Enrollment
80
Registered
2023-03-29
Start date
2023-09-19
Completion date
Unknown
Last updated
2023-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetric perineal lacerations

Brief summary

Pain/discomfort (perprocedural)

Detailed description

Preprocedural anxiety, Time of repair the perineal laceration, Ability to have skin-to-skin contact with baby during perineal repair, Time until micturition after the perineal repair, Procedure feasibility, Amount of drugs used during perineal repair, Use of pain relief 24h postpartum, Patient experience after repair of perineal laceration 4 days postpartum, Need of pain-relieving within 24 h postpartum, Time to mobilisation of the patient, Time to micturition, Perprocedural anxiety

Interventions

DRUGROPIVACAINE
DRUGLIDOCAINE
DRUGPROPOFOL
DRUGMEPIVACAINE

Sponsors

Region Oestergoetland
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Pain/discomfort (perprocedural)

Secondary

MeasureTime frame
Preprocedural anxiety, Time of repair the perineal laceration, Ability to have skin-to-skin contact with baby during perineal repair, Time until micturition after the perineal repair, Procedure feasibility, Amount of drugs used during perineal repair, Use of pain relief 24h postpartum, Patient experience after repair of perineal laceration 4 days postpartum, Need of pain-relieving within 24 h postpartum, Time to mobilisation of the patient, Time to micturition, Perprocedural anxiety

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026